Market revenue in 2020 | USD 208.2 million |
Market revenue in 2028 | USD 292.8 million |
Growth rate | 4.4% (CAGR from 2020 to 2028) |
Largest segment | Reagents |
Fastest growing segment | Reagents |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 66.23% in 2020. Horizon Databook has segmented the Saudi Arabia infectious disease molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2028.
The infectious diseases molecular diagnostics market in Saudi Arabia is likely to exhibit a CAGR of 4.4% during the forecast period. High unmet clinical needs, rise in disposable income, and increase in number of collaborative agreements with international organizations, such as WHO and United Nations, are creating opportunities for growth of infectious disease molecular diagnostics market in Saudi Arabia.
Moreover, increase in incidence of infectious diseases is expected to drive market growth. For instance, according to the WHO, in 2017, prevalence of hepatitis B in those above 5 years of age was 2.24% and estimated number of carriers was 636,000.
However, as per a study by NCBI in 2019, only 14% of the cases are diagnosed in the region. This gap is creating an opportunity for molecular diagnostics. In addition, due to rising number of COVID-19 cases in the country, the government entered into a USD 264 million deal for COVID-19 tests with China in April 2020.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia infectious disease molecular diagnostics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account